Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct;16(10):1584-6.
doi: 10.3201/eid1610.100242.

Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus

Affiliations

Mortality rate patterns for hemorrhagic fever with renal syndrome caused by Puumala virus

Marika Hjertqvist et al. Emerg Infect Dis. 2010 Oct.

Abstract

To investigate nephropathia epidemica in Sweden during 1997-2007, we determined case-fatality rates for 5,282 patients with this disease. Overall, 0.4% died of acute nephropathia epidemica ≤3 months after diagnosis. Case-fatality rates increased with age. Only women showed an increased case-fatality rate during the first year after diagnosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of acute nephropathia epidemica (NE) and case-fatality rates, Sweden, 1997–2007. A) Age distribution for male and female patients with acute NE. B) Age distribution of case-fatality rates for all patients with acute NE. The Swedish Death Register was used to identify all deceased persons with a diagnosis of NE. Numbers of deaths during different periods after diagnoses were 21 (13 male patients and 8 female patients) during the acute phase (<3 months after diagnoses), 7 (5 male patients and 2 female patients) after the acute phase (>3 months after diagnoses) but <1 year later, and 24 (19 male patients and 5 female patients) during the second year after diagnoses.
Figure 2
Figure 2
Overall standardized mortality ratios (SMRs) for male and female patients with a diagnosis of acute nephropathia epidemica (NE) and SMRs 3–12 mo after diagnosis, Sweden, 1997–2007.

References

    1. Vapalahti O, Mustonen J, Lundkvist Å, Henttonen H, Plyusnin A, Vaheri A. Hantavirus infections in Europe. Lancet Infect Dis. 2003;3:653–61. 10.1016/S1473-3099(03)00774-6 - DOI - PubMed
    1. Schmaljohn C, Hjelle B. Hantaviruses: a global disease problem. Emerg Infect Dis. 1997;3:95–104. 10.3201/eid0302.970202 - DOI - PMC - PubMed
    1. Settergren B. Clinical aspects of nephropathia epidemica (Puumala virus infection) in Europe: a review. Scand J Infect Dis. 2000;32:125–32. 10.1080/003655400750045204 - DOI - PubMed
    1. Schönrich G, Rang A, Lütteke N, Raftery M, Charbonnel N, Ulrich R. Hantavirus-induced immunity in rodent reservoirs and humans. Immunol Rev. 2008;225:163–89. 10.1111/j.1600-065X.2008.00694.x - DOI - PubMed
    1. Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev. 2000;24:627–38. 10.1016/S0149-7634(00)00027-0 - DOI - PubMed

Publication types

LinkOut - more resources